Entecavir safety and effectiveness in a national cohort of treatment‐naïve chronic hepatitis B patients in the <scp>US</scp> – the <scp>ENUMERATE</scp> study

Abstract

Entecavir treatment was safe in a large cohort of US patients, but ALT normalisation and hepatitis B virus DNA suppression rates were lower than previously reported in clinical trials.